<DOC>
	<DOCNO>NCT02290210</DOCNO>
	<brief_summary>The purpose study assess safety , PK/PD Urate Lowering Effect URC102 gout patient hyperuricemia</brief_summary>
	<brief_title>Phase 2 Study URC102 Assess Efficacy Safety Gout Patients</brief_title>
	<detailed_description />
	<mesh_term>Gout</mesh_term>
	<mesh_term>Hyperuricemia</mesh_term>
	<criteria>Diagnosed gout Participated clinical study within 12 week prior enrollment , receive investigational product ( include placebo )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>